Concourse Financial Group Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,677
| Closed | -$2.86M | – | 8223 |
|
|
2024
Q4 | $2.86M | Buy |
6,677
+1,786
| +37% | +$764K | 0.16% | 132 |
|
|
2024
Q3 | $2.27M | Sell |
4,891
-22
| -0.4% | -$10.2K | 0.14% | 157 |
|
|
2024
Q2 | $2.3M | Buy |
4,913
+89
| +2% | +$41.7K | 0.14% | 150 |
|
|
2024
Q1 | $2.02M | Buy |
4,824
+710
| +17% | +$297K | 0.13% | 163 |
|
|
2023
Q4 | $1.67M | Buy |
4,114
+1,301
| +46% | +$529K | 0.12% | 176 |
|
|
2023
Q3 | $978K | Buy |
2,813
+264
| +10% | +$91.8K | 0.08% | 261 |
|
|
2023
Q2 | $897K | Buy |
2,549
+107
| +4% | +$37.7K | 0.07% | 295 |
|
|
2023
Q1 | $769K | Buy |
2,442
+623
| +34% | +$196K | 0.06% | 329 |
|
|
2022
Q4 | $525K | Buy |
1,819
+554
| +44% | +$160K | 0.04% | 402 |
|
|
2022
Q3 | $366K | Sell |
1,265
-324
| -20% | -$93.7K | 0.03% | 418 |
|
|
2022
Q2 | $448K | Sell |
1,589
-1,425
| -47% | -$402K | 0.04% | 417 |
|
|
2022
Q1 | $787K | Sell |
3,014
-3,308
| -52% | -$864K | 0.06% | 327 |
|
|
2021
Q4 | $1.39M | Buy |
6,322
+303
| +5% | +$66.5K | 0.08% | 245 |
|
|
2021
Q3 | $1.09M | Buy |
6,019
+1,616
| +37% | +$293K | 0.07% | 289 |
|
|
2021
Q2 | $888K | Sell |
4,403
-3,375
| -43% | -$681K | 0.06% | 326 |
|
|
2021
Q1 | $1.67M | Buy |
7,778
+2,736
| +54% | +$588K | 0.12% | 156 |
|
|
2020
Q4 | $1.19M | Buy |
5,042
+1,545
| +44% | +$365K | 0.09% | 195 |
|
|
2020
Q3 | $952K | Buy |
3,497
+748
| +27% | +$204K | 0.08% | 204 |
|
|
2020
Q2 | $798K | Buy |
2,749
+1,109
| +68% | +$322K | 0.08% | 206 |
|
|
2020
Q1 | $390K | Buy |
1,640
+552
| +51% | +$131K | 0.04% | 301 |
|
|
2019
Q4 | $238K | Buy |
1,088
+441
| +68% | +$96.5K | 0.02% | 462 |
|
|
2019
Q3 | $110K | Buy |
647
+2
| +0.3% | +$340 | 0.03% | 419 |
|
|
2019
Q2 | $118K | Buy |
645
+234
| +57% | +$42.8K | 0.01% | 623 |
|
|
2019
Q1 | $75K | Buy |
411
+282
| +219% | +$51.5K | 0.01% | 750 |
|
|
2018
Q4 | $21K | Buy |
129
+74
| +135% | +$12K | ﹤0.01% | 1140 |
|
|
2018
Q3 | $11K | Buy |
+55
| New | +$11K | ﹤0.01% | 1075 |
|